| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
-: ACOR |
| Security Type |
Common Stock |
| Lead Underwriter |
Banc of America Securities LLC |
| Days In Registration |
78 |
| Date Filed |
29-Sep-2003 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Acorda Therapeutics Inc, located in Hawthorne, New York, is a biotechnology company that develops therapies for spinal cold injury, multiple sclerosis and related nervous system disorders. The company's pipeline includes a number of products in the development for the treatment, regeneration and repair of the spinal cord and brain. Its brands include Zanaflex Capsules. The company was founded in 1995. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
20.86M |
| Contact |
- |
| Number of Employees |
144 |
|
| Original Filing Information |
| US |
| Shares Filed |
4.8M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
720.0K |
| File Amount |
- |
| File Price Range |
$14.00 - $12.00 |
| File Mid Price |
$13.00 |
|
